JP2002518354A5 - - Google Patents

Download PDF

Info

Publication number
JP2002518354A5
JP2002518354A5 JP2000554568A JP2000554568A JP2002518354A5 JP 2002518354 A5 JP2002518354 A5 JP 2002518354A5 JP 2000554568 A JP2000554568 A JP 2000554568A JP 2000554568 A JP2000554568 A JP 2000554568A JP 2002518354 A5 JP2002518354 A5 JP 2002518354A5
Authority
JP
Japan
Prior art keywords
compound according
amino acid
compound
linked
tyrosine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000554568A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002518354A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/013455 external-priority patent/WO1999065712A2/en
Publication of JP2002518354A publication Critical patent/JP2002518354A/ja
Publication of JP2002518354A5 publication Critical patent/JP2002518354A5/ja
Withdrawn legal-status Critical Current

Links

JP2000554568A 1998-06-16 1999-06-15 糖硫酸ペプチド、その合成方法および使用方法 Withdrawn JP2002518354A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8947298P 1998-06-16 1998-06-16
US60/089,472 1998-06-16
PCT/US1999/013455 WO1999065712A2 (en) 1998-06-16 1999-06-15 Glycosulfopeptides and methods of synthesis and use thereof

Publications (2)

Publication Number Publication Date
JP2002518354A JP2002518354A (ja) 2002-06-25
JP2002518354A5 true JP2002518354A5 (enExample) 2006-08-10

Family

ID=22217840

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000554568A Withdrawn JP2002518354A (ja) 1998-06-16 1999-06-15 糖硫酸ペプチド、その合成方法および使用方法

Country Status (8)

Country Link
US (4) US6593459B1 (enExample)
EP (1) EP1087996B1 (enExample)
JP (1) JP2002518354A (enExample)
AU (1) AU773542B2 (enExample)
CA (1) CA2332563A1 (enExample)
DE (1) DE69934890D1 (enExample)
MX (1) MXPA00012586A (enExample)
WO (1) WO1999065712A2 (enExample)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7223845B2 (en) 1998-06-16 2007-05-29 The Board Of Regents Of The University Of Oklahoma Synthetic glycosulfopeptides and methods of synthesis thereof
AU773542B2 (en) * 1998-06-16 2004-05-27 Board Of Regents Of The University Of Oklahoma, The Glycosulfopeptides and methods of synthesis and use thereof
US20030143662A1 (en) 1998-06-16 2003-07-31 Cummings Richard D. Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof
US6492152B1 (en) 1999-06-15 2002-12-10 The Board Of Regents Of The University Of Oklahoma Core 1 β3-galactosyl transferases and methods of use thereof
MXPA02005953A (es) * 1999-12-15 2003-01-28 Univ Oklahoma Beta 3-galactosil transferasas de nucleo 1 y metodos de uso de las mismas.
EP1325123A4 (en) * 2000-09-12 2004-07-21 Inst Genetics Llc INHIBITION OF STENOSIS OR RESTENOSIS USING P-SELECTINE ANTAGONISTS
SE0004828D0 (sv) * 2000-12-22 2000-12-22 Pharmacia Ab Protein cluster II
US7132510B2 (en) * 2000-12-29 2006-11-07 Bio-Technology General (Israel) Ltd. Specific human antibodies for selective cancer therapy
US20040002450A1 (en) * 2000-12-29 2004-01-01 Janette Lazarovits Y17 - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
US20040001822A1 (en) * 2000-12-29 2004-01-01 Avigdor Levanon Y1-isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
CA2433225A1 (en) * 2000-12-29 2002-07-11 Bio-Technology General, Inc. Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
US20040001839A1 (en) * 2000-12-29 2004-01-01 Avigdor Levanon Multimers - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
US6537780B2 (en) * 2001-03-28 2003-03-25 Applera Corporation Isolated nucleic acid molecules encoding transferase enzymes
WO2003032925A2 (en) * 2001-10-19 2003-04-24 Cummings Richard D Glycosulfopeptide inhibitors and methods of use thereof
AU2003249641B2 (en) * 2002-05-16 2009-08-20 Glycomimetics, Inc. Compounds and methods for inhibiting selectin-mediated function
US20040202665A1 (en) * 2002-07-01 2004-10-14 Janette Lazarovits Compositions and methods for therapeutic treatment
JP2006502986A (ja) * 2002-07-03 2006-01-26 グリコミメティクス, インコーポレイテッド 新脈管形成に関与する医学的状態の診断および治療のための組成物および方法
US20040219158A1 (en) * 2003-05-02 2004-11-04 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria
US20050069955A1 (en) * 2003-06-30 2005-03-31 Daniel Plaksin Antibodies and uses thereof
US20050152906A1 (en) * 2003-06-30 2005-07-14 Avigdor Levanon Specific human antibodies
US20050266009A1 (en) * 2003-06-30 2005-12-01 Savient Pharmaceuticals, Inc. Antibodies and uses thereof
US20050187171A1 (en) * 2003-11-19 2005-08-25 Glycomimetics, Inc. Glycomimetic antagonists for both E-and P-selectins
ATE383367T1 (de) * 2003-11-19 2008-01-15 Glycomimetics Inc Spezifischer antagonist sowohl für e- als auch p- selektine
WO2005081904A2 (en) * 2004-02-20 2005-09-09 The Burnham Institute Antimicrobial carbohydrates and methods of using same
US8201377B2 (en) * 2004-11-05 2012-06-19 Faus Group, Inc. Flooring system having multiple alignment points
TWI264608B (en) * 2005-04-08 2006-10-21 Delta Electronics Inc Light tunnel module
WO2006127906A1 (en) * 2005-05-25 2006-11-30 Glycomimetics, Inc. Heterobifunctional compounds for selectin inhibition
ATE528311T1 (de) * 2005-08-09 2011-10-15 Glycomimetics Inc Glycomimetische inhibitoren des pa-il-lectins, pa-iil-lectins oder beider lectine aus pseudomonas
SI1934236T1 (sl) 2005-09-02 2013-02-28 Glycomimetics, Inc. Heterobifunkcionalni inhibitorji pan-selektina
US20090176717A1 (en) * 2006-06-01 2009-07-09 Glycomimetics, Inc. Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas
JP5298020B2 (ja) 2006-10-12 2013-09-25 グリコミメティクス, インコーポレイテッド ヘキソースおよびn−アセチルヘキソサミンの糖模倣体置換
CA2677747A1 (en) * 2007-02-09 2008-08-21 Glycomimetics, Inc. Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
US8039442B2 (en) 2007-07-18 2011-10-18 Glycomimetics, Inc. Compounds and methods for treatment of sickle cell disease or complications associated therewith
AU2008336249B2 (en) 2007-12-10 2015-01-29 The University Of Queensland Treatment and prophylaxis
US8895510B2 (en) * 2008-04-08 2014-11-25 Glycomimetics, Inc. Pan-selectin inhibitor with enhanced pharmacokinetic activity
CA2727788A1 (en) * 2008-06-13 2009-12-17 Glycomimetics, Inc. Treatment of cancers of the blood using selected glycomimetic compounds
CN102421441B (zh) 2009-05-01 2015-04-01 糖模拟物有限公司 E-选择蛋白和cxcr4趋化因子受体的异双功能抑制剂
US8921328B2 (en) 2010-09-14 2014-12-30 Glycomimetics, Inc. E-selectin antagonists
HUE037992T2 (hu) 2010-12-21 2018-09-28 Selexys Pharmaceuticals Corp Anti-P-szelektin antitestek és eljárások azok alkalmazására és azonosítására
KR102055958B1 (ko) 2011-12-22 2019-12-13 글리코미메틱스, 인크. E-셀렉틴 길항제 화합물, 조성물, 및 이용 방법
CA2891514C (en) 2012-12-07 2020-08-25 Glycomimetics, Inc. Compounds, compositions and methods using e-selectin antagonists for mobilization of hematopoietic cells
EP3004139B1 (en) 2013-06-03 2020-05-06 Emory University Selectin inhibitors, composition, and uses related thereto
PT3227310T (pt) 2014-12-03 2019-11-06 Glycomimetics Inc Inibidores heterobifuncionais de e-selectinas e recetores de quimiocina cxcr4
CA3009836A1 (en) 2016-01-22 2017-07-27 Glycomimetics, Inc. Glycomimetic inhibitors of pa-il and pa-iil lectins
WO2017151708A1 (en) 2016-03-02 2017-09-08 Glycomimetics, Inc. Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin
US11433086B2 (en) 2016-08-08 2022-09-06 Glycomimetics, Inc. Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4
CN109890421B (zh) 2016-10-07 2023-10-20 糖模拟物有限公司 高效的多聚体e-选择蛋白拮抗剂
CA3054605A1 (en) 2017-03-15 2018-09-20 Glycomimetics, Inc. Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists
JP7275131B2 (ja) 2017-11-30 2023-05-17 グリコミメティクス, インコーポレイテッド 骨髄浸潤リンパ球を動員する方法、およびその使用
AU2018395417B2 (en) 2017-12-29 2023-07-13 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3
WO2019173229A1 (en) 2018-03-05 2019-09-12 Glycomimetics, Inc. Methods for treating acute myeloid leukemia and related conditions
EA202092934A1 (ru) * 2018-06-11 2021-04-05 Дзе Уистар Инститьют Оф Энэтоми Энд Байолоджи Композиции и способы для посттрансляционной модификации in vivo
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3
AU2020209822A1 (en) 2019-01-15 2021-09-09 Optimvia, Llc Engineered aryl sulfate-dependent enzymes
BR112022000255A8 (pt) 2019-07-09 2022-03-22 Optimvia Llc Métodos para sintetizar polissacarídeos anticoagulantes

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
JPS60197699A (ja) * 1984-03-19 1985-10-07 Fuji Yakuhin Kogyo Kk コレシストキニンパンクレオザイミンc端ペプチドおよびその類縁体の製造方法
US5874261A (en) 1988-09-02 1999-02-23 The Trustees Of The University Of Pennsylvania Method for the purification of glycosyltransferases
US5047335A (en) 1988-12-21 1991-09-10 The Regents Of The University Of Calif. Process for controlling intracellular glycosylation of proteins
US5929036A (en) 1989-03-08 1999-07-27 The Board Of Regents Of The University Of Oklahoma Ligand or GMP-140 selectin and methods of use thereof
EP0481038B1 (en) 1990-04-16 2002-10-02 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US5766897A (en) * 1990-06-21 1998-06-16 Incyte Pharmaceuticals, Inc. Cysteine-pegylated proteins
AU3914393A (en) * 1991-12-18 1994-03-15 Board Of Regents Of The University Of Oklahoma, The Peptide inhibitors of inflammation mediated by selectins
JPH0686684A (ja) 1992-05-26 1994-03-29 Monsanto Co シアロ抱合体の合成
US5382657A (en) * 1992-08-26 1995-01-17 Hoffmann-La Roche Inc. Peg-interferon conjugates
WO1994005314A1 (en) * 1992-09-08 1994-03-17 Centocor, Inc. Peptide inhibitors of leukocyte adhesion
US5843707A (en) 1992-10-23 1998-12-01 Genetics Institute, Inc. Nucleic acid encoding a novel P-selectin ligand protein
EP0668907A1 (en) 1992-11-16 1995-08-30 Board Of Regents Of The University Of Oklahoma Glycoprotein ligand for p-selectin and methods of use thereof
SE504074C2 (sv) * 1993-07-05 1996-11-04 Pharmacia Ab Proteinberedning för subkutan, intramuskulär eller intradermal administrering
US5730990A (en) * 1994-06-24 1998-03-24 Enzon, Inc. Non-antigenic amine derived polymers and polymer conjugates
FR2723962B1 (fr) * 1994-08-25 1996-10-31 Univ Paris Curie Hsv1-tk modifiee fonctionnelle
US5821329A (en) 1996-06-06 1998-10-13 Tanabe Seiyaku Co., Ltd. Cyclic peptide inhibitors of β1 and β2 integrin-mediated adhesion
KR100523506B1 (en) 1995-08-03 2005-10-24 Peptide and O-glycan inhibitors of selectin mediated inflammation
EP0959905B1 (en) * 1997-01-21 2009-12-09 Sanofi Pasteur Polysaccharide-peptide-conjugates
US6180096B1 (en) * 1998-03-26 2001-01-30 Schering Corporation Formulations for protection of peg-interferon alpha conjugates
AU773542B2 (en) * 1998-06-16 2004-05-27 Board Of Regents Of The University Of Oklahoma, The Glycosulfopeptides and methods of synthesis and use thereof
US6165509A (en) * 1998-09-01 2000-12-26 University Of Washington Pegylated drug complexed with bioadhesive polymer suitable for drug delivery and methods relating thereto
US6432409B1 (en) * 1999-09-14 2002-08-13 Antigen Express, Inc. Hybrid peptides modulate the immune response

Similar Documents

Publication Publication Date Title
JP2002518354A5 (enExample)
Andreasen et al. Treatment of crown fractured incisors with laminate veneer restorations. An experimental study
CA2115170A1 (en) Imidazolyl-alkenoic acids
JP2003535043A5 (enExample)
EP2261351A3 (en) Neisseria meningitidis antigens and compositions
JP2003519099A5 (enExample)
WO2003037271A3 (en) Compounds, pharmaceutical compositions and methods of use therefor
EP1382897A3 (en) A monitor support
DK1041967T3 (da) Mikropartikler og deres terapeutiske eller diagnostiske anvendelse
CA2389440A1 (en) Anti-snoring device and method of making same
JP2003534287A5 (enExample)
JP2010512326A5 (enExample)
JP2005080553A5 (enExample)
JP2000169695A5 (enExample)
CA2299013A1 (en) Neuropeptide y antagonists
JP2000095900A5 (enExample)
TWI254925B (en) DVD player attachable to planar display
Shapiro Osteogenesis imperfecta and other defects of bone development as occasional causes of adult osteoporosis
JP2001515063A5 (enExample)
CN208719587U (zh) 大型组合管道防冷桥固定支架
JP2003105259A5 (enExample)
AU2003236714A8 (en) Diagnosis of alzheimer's disease based on the habeta42:habeta40 ratio
JP2006524032A5 (enExample)
JP2004010863A5 (enExample)
JPH10210974A5 (enExample)